Clinical Trial

Evaluation of CUDECA Cui-DAR Plan in People With Oncological and Non-oncological Diseases in the Last Days of Their Lives (CUIDARCUDECA)

Study acronym: CUIDARCUDECA
Completed
View on ClinicalTrials.gov →
Summary
Cudeca, an independent non-profit organization located in Malaga (Spain), treats patients with advanced and terminal disease. It has developed Cui-DAR Cudeca plan, a care plan for the care of patients in situations of last days of thier live that integrates in a single document, all the assessments and multidisciplinary actions necessary, from the beginning of last days situation, to the care after death. The objective of the study is to evaluate the validity and effectiveness of the Cui-DAR CUDECA Plan in people in a situation of last days compared to conventional care in the assessment of symptoms and signs.
Trial Details
NCT Number NCT07446673
Lead Sponsor Cudeca Hospice Foundation
Conditions Patients in Situation of Last Days of Their Life, Oncological and no Onoclogical Disease
Enrollment 348 participants
Start Date 2022-01-27
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-02-20 (estimated)
Updated on ClinicalTrials.gov 2026-03-03